Ideas

Thinking on compliance, supply chain
intelligence, and the policy that shapes it.

Published

March 22, 2026

Topic

Industry

My thoughts on Delve

A $32 million series A compliance company is at the center of a fraud investigation that has the RegTech sector dumbfounded.

Read

Published

March 20, 2026

Topic

Policy

BIOSECURE Compliance Alone Won't Save You

Firms focused only on surface-level BIOSECURE compliance may be missing the larger signal about biotech supply chain transparency.

Read

© 2026 Biogate, Inc.

Pre-audit analysis. Not legal advice.